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miRNAs play critical roles in various biological processes by targeting
specific mRNAs. Current approaches to identifyingmiRNA targets are
insufficient for elucidation of a miRNA regulatory network. Here, we
created a cell-based screening system using a luciferase reporter library
composed of 4,891 full-length cDNAs, each of which was integrated
into the 3′ UTR of a luciferase gene. Using this reporter library system,
we conducted a screening for targets of miR-34a, a tumor-suppressor
miRNA. We identified both previously characterized and previously
uncharacterized targets.miR-34aoverexpression inMDA-MB-231breast
cancer cells repressed the expression of these previously unrecognized
targets. Among these targets, GFRA3 is crucial for MDA-MB-231 cell
growth, and its expression correlated with the overall survival of pa-
tients with breast cancer. Furthermore, GFRA3was found to be directly
regulated by miR-34a via its coding region. These data show that this
system is useful for elucidating miRNA functions and networks.
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MicroRNAs are small noncoding RNAs that repress theirtarget genes at the posttranscriptional level by binding as
part of the RISC (RNA-induced silencing complex) to regions
usually within the 3′ UTR of the target mRNAs. Identifying the
targets of miRNAs is critical for understanding their function;
however, the current methods used to analyze specific targets in
intact cells are not adequate.
Identification of miRNA targets often involves a combination of
the following approaches: transcriptome analysis, in silico pre-
diction tools, transcriptome-wide miRNA–mRNA interaction
analysis, and cell-based screening systems. Transcriptome analysis,
such as microarray or high-throughput RNA sequencing (RNA-
seq) with or without specific miRNAs, may find putative target
transcripts whose stability is significantly decreased by the miRNA.
However, the targets of the miRNA, which are regulated at the
level of translation, may not always correspond to the protein levels
(1–3). Current computational tools for prediction of miRNA tar-
gets such as TargetScan (4) predict target candidates by miRNA–
mRNA sequence matches; however, these candidates have many
false positives, and most information regarding the target regions
from these prediction tools is restricted to the mRNA’s 3′ UTR.
Transcriptome-wide miRNA–mRNA interaction analysis, including
RNA-binding protein immunoprecipitation-sequencing (RIP-seq)
(5, 6) and high-throughput sequencing of RNA isolated by cross-
linking immunoprecipitation (HITS-CLIP) (7–10) using the Argo-
naute (Ago) protein, which is a major RISC component, enables
global mapping of Ago-binding sequences. Sequencing of target
transcripts captured by biotinylated miRNA mimics also has been
reported (11). However, the transcripts detected by these methods
are not always functional targets. Finally, cell-based screening sys-
tems also have been reported. 3′LIFE, reported by Wolter et al., is
a screening system for functional miRNA targets and is based on a
luciferase reporter library of 275 human 3′ UTRs; this system
sensitively identified the targets of let-7c and miR-10b (12, 13).
Recently, the same group reported a reporter library of a larger
scale. They constructed a luciferase reporter library of 1,461 human
3′ UTRs, termed the “human 3′UTRome v1 clone collection” (h3′
UTRome v1), which consists of human 3′ UTRs from transcription
factors, kinases, and RNA-binding proteins (14). This system allows
screening individual miRNAs without biasing the screen toward
candidate genes identified bioinformatically, enabling the identifi-
cation of genes targeted via noncanonical and poorly conserved
interactions. On the other hand, the 3′-UTR library is not suffi-
ciently large-scale, and the target region is restricted to the 3′ UTR.
To overcome this problem, we developed a luciferase assay-based
target screening system. Using cDNAs from the Mammalian Gene
Collection (MGC) plasmids and the Gateway recombination system,
we constructed a reporter plasmid library in which the luciferase
gene includes 4,891 nonbiased cDNA sequences in the 3′ UTR.
Screening for miRNA targets was conducted by luciferase assays on
the reporter library with or without an expression vector for the
miRNA of interest. This system allows us to evaluate the putative
direct targets of specific miRNAs functionally through its full-length
sequence not only at the mRNA level but also at the protein level.
To verify this system, we focused on miR-34a and conducted a
screening for its targets. miR-34a is a downstream miRNA of the
Significance
Identification of miRNA targets is necessary for understanding
their functions; however, current approaches to screening for
specific targets are inadequate. For example, most miRNA target-
prediction tools only match the 3′-UTR sequence with the miRNA
sequence. We created a screening system for miRNA targets using
a reporter library of 4,891 full-length cDNAs inserted into the 3′
UTR of a luciferase gene. Using this system, we identified targets
of tumor suppressor miR-34a. Among the identified targets,
GFRA3, which is crucial for growth of breast cancer cells and af-
fects the survival of patients with breast cancer, was directly
regulated by miR-34a via the coding region. Our study shows the
advantage of this full-length reporter library system in identifying
functional targets of miRNAs.
Author contributions: Y.I., A. Inoue, and H.A. designed research; Y.I., A. Inoue, T.S., Y.H.,
A. Igarashi, and T.T. performed research; Y.I., A. Inoue, and H.A. contributed new re-
agents/analytic tools; Y.I., A. Inoue, T.S., Y.H., T.T., K.D.T., M.P.B., and H.A. analyzed data;
and Y.I. and H.A. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
1To whom correspondence should be addressed. Email: asahara.syst@tmd.ac.jp.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1620019114/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1620019114 PNAS | April 11, 2017 | vol. 114 | no. 15 | 3927–3932
CE
LL
BI
O
LO
G
Y
tumor suppressor p53 (15–17). Decreased expression of miR-34a
has been reported in various cancers (18–20), and miR-34a plays a
critical role in cell-cycle arrest, apoptosis, senescence, and in-
hibition of the epithelial–mesenchymal transition (15, 16, 21–24),
indicating that miR-34a is a crucial target of p53 because of its
tumor-suppressor function. Although this p53–miR-34a axis is
widely known, the above-mentioned potential functions of miR-
34a are not fully explained by our limited information regarding
the downstream molecular network of miR-34a. Our successful
application of the newly created reporter library screening assay
systematically identified functional targets of miR-34a without a
bias. In addition, our results showed thatGFRA3, one of the newly
identified targets of miR-34a, regulates the growth of breast
cancer cells, and miR-34a regulates it directly via its coding region.
These results suggest that this library system can be an important
alternative and complementary approach to surveying miRNA-
dependent molecular networks and functions.
Results
Construction of the Reporter Library. To develop the screening
system for identifying the targets of miRNAs, we created a reporter
plasmid library. This reporter vector library, which consisted of
4,891 full-length cDNAs in the 3′ UTR of the luc2 gene, was
constructed by BP Clonase recombination of pLuc2-KAP-ccdB (Fig.
S1 A and C) and the MGC library (Fig. S2) or by inserting a PCR-
amplified cDNA into the multiple cloning site of pLuc2-KAP-MCS
(Fig. S1B). Cloned cDNAs ranged in size from 290 to 8,472 bp, with
an average size of 2,154.3 bp (Dataset S1). The size distribution of
the cloned reporter library cDNAs is shown in Fig. S3. These
plasmids were purified, and the concentrations were measured.
They were diluted and dispensed into 384-well plates (Fig. S2) that
then were used as assay plates. A miRNA expression vector was
cotransfected with the reporter library in the assay plates, and targets
were screened by measuring changes in luc2 reporter activity (Fig. 1).
To confirm the functionality of these reporters, we first per-
formed luciferase assays using an expression vector with miR-34a,
a transcriptional target miRNA of p53 and a proposed tumor
suppressor (25), as well as reporters of its putative targets SIRT1
(Sirtuin 1), BCL2 (B-cell lymphoma 2), CDK6 (cyclin-dependent
kinase 6), MYC (v-myc avian myelocytomatosis viral oncogene
homolog), and CREB1 (cAMP-responsive element-binding protein
1) (20, 22, 25–31). However, miR-34a repressed the luciferase
activities of only the SIRT1 and BCL2 reporters; the CDK6, MYC,
and CREB1 reporter activities were not repressed (Fig. S4 A and C
and Tables S1 and S3). We speculated that nonsense-mediated
mRNA decay (NMD) was the cause. The function of NMD is to
reduce errors in gene expression by eliminating mRNA transcripts
that contain premature termination codons (PTCs) (Fig. S5) (32,
33). In addition, the length of the 3′ UTR influences the NMD
pathway. A number of studies have revealed that artificial 3′ UTRs
800–900 bp in length promote NMD (34–41). The average length
of the 3′ UTRs in our reporters is more than 2,000 bp, suggesting
that the reporters may be affected by NMD, which would decrease
observable changes in the reporter activities under the influence of
miRNA. We first performed a luciferase assay using known miR-
34a target reporters with two siRNAs for UPF1, the central com-
ponent of the NMD pathway (33). The luciferase activities of the
MYC and CREB1 reporters were decreased by miR-34a when
UPF1 was knocked down (red boxes in Fig. S4 A and B and Tables
S1 and S2). Furthermore, we performed luciferase assays with an
NMD inhibitor. SMG1, a phosphoinositide 3-kinase–like kinase,
phosphorylates UPF1, and this phosphorylation is crucial for NMD
(33). Wortmannin is an inhibitor of the kinase SMG1 and thus
inhibits NMD (Fig. S5) (42, 43). The rescue effect seen with the
UPF1 knockdown also was detected using wortmannin (Fig. S4
C and D and Table S3). These data suggest that screening
Fig. 1. A schematic model of the reporter library system for screening of
miRNA targets. CMVp, cytomegalovirus promoter; pA, polyA signal; SV40p,
simian virus 40 promoter.
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Fig. 2. The reporter library system identified targets of miR-34a. (A) The
screening process. Initially, a screening in 384-well plates with 4,891 reporters
was performed, and the top 70 genes were selected. Second, 384-well plate
luciferase assays were carried out in triplicate, and 22 genes with reproducible
results were selected. Third, 96-well plate luciferase assays were conducted in
duplicate four times independently, and 12 targets were identified. (B) Lucif-
erase assays of various reporters in 293FT cells transfected with pcDNA-miR-
34a (miR-34a) or the empty vector (Ctrl). 3U, 3′ UTR; MCS, pLuc2-KAP-MCS
(empty reporter). Error bars show SD; n = 8. (C) Relative mRNA expression
of FAM76A, GFRA3, CARKL, and REM2 in MDA-MB-231 cells transfected with
the negative control miRNA mimic (Ctrl) or miR-34a mimic. (D and E) Western
blots (D) and quantification (E) of protein expression of FAM76A, GFRA3,
CARKL, REM2, and β-actin in MDA-MB-231 cells transfected with the negative
control miRNA mimic (Ctrl) or miR-34a mimic. (F) Luciferase assays of whole
and fragmented reporters in 293FT cells transfected with pcDNA-miR-34a
(miR-34a) or empty vector (Ctrl). *P < 0.05, **P < 0.01, ***P < 0.001.
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of targets of miRNA with an NMD inhibitor can increase assay
sensitivity.
A Cell-Based Screening System Using the Reporter Library-Identified
miRNA Targets. To evaluate the reporter library system with the
NMD inhibitor wortmannin, we conducted a screening for potential
targets of miR-34a. The screening procedure is shown in Fig. 2A.
As a result, we identified eight reported miR-34a targets (SIRT1,
SEMA4B, BCL2,MYB, CREB1, CSF1R,MYC, and REF1) (20, 44–
48) and four previously unreported miR-34a targets (FAM76A,
GFRA3, CARKL, and REM2) (Fig. 2B). Reporters of FAM76A
(family with sequence similarity 76, member A) and GFRA3 (glial
cell line-derived neurotrophic factor family receptor alpha 3) were
significantly inhibited by miR-34a (Fig. 2B). We next searched for
miR-34a target sites in these identified transcripts using TargetScan,
a miRNA target prediction tool (www.targetscan.org/vert_71/)
(4). BCL2, CSF1R, SEMA4B, LEF1, and FAM76A have conserved
miR-34a target sites, whereas SIRT1, MYB, CREB1, and GFRA3
have poorly conserved miR-34a target sites in their 3′ UTRs (Fig.
S6). Other target candidates (MYC, CARKL, and REM2) did not
have TargetScan-predicted miR-34a target sites, suggesting that
this reporter system may identify miRNA targets not found by
miRNA target-prediction tools. In addition, we investigated the
expression of these previously unidentified target candidates in
miR-34a–overexpressing MDA-MB-231 human breast cancer
cells. The mRNA levels of FAM76A and GFRA3 were repressed
by the overexpression of a miR-34a mimic in MDA-MB-231 cells,
but mRNA levels of CARKL and REM2 were not significantly
changed compared with the negative control (Fig. 2C). In addi-
tion, the mRNA expression of SEMA4B, CREB1, and MYC was
not reduced by miR-34a overexpression, although other identified
targets (SIRT1, BCL2, MYB, CSF1R, and LEF1) were down-
regulated (Fig. S7). However, protein levels of FAM76A, GFRA3,
CARKL, and REM2 were reduced in miR-34a–overexpressing
MDA-MB-231 cells (Fig. 2 D and E). These data indicate that
miR-34a regulates the expression of these four target candidates
and suggest that this system can identify the targets of the miRNA
that are regulated at the level of translation. We next carried out
luciferase assays with fragmented reporters. Although the reporters
of FAM76A and REM2 were regulated by miR-34a via their 3′
UTR, the reporters of GFRA3 and CARKL were regulated via
their coding region (Fig. 2F), highlighting the significance of re-
porters containing whole-length cDNA sequences. Our system
identified 12 targets of miR-34a, and two of these targets (16.7%)
were regulated by miR-34a via their coding region.
Furthermore, we used our system for screening with miR-146a,
a miRNA crucial for inflammation, and identified six previously
unreported miR-146a target candidates (RABL2B, CABLES1,
TSCOT, BMP5, TM4SF19, and ABHD5) as well as the previously
reported targets TRAF6, IRAK1, and CXCR4 (Fig. S8), suggesting
that the reporter library system is useful for screening the targets
of various miRNAs.
GFRA3 Was Directly Regulated by miR-34a via Its Coding Region. To
determine whether these identified targets were directly regulated
by miR-34a, we focused on FAM76A andGFRA3, whose reporters
were significantly down-regulated by miR-34a, and performed a
reporter assay using various fragmented and point-mutated re-
porters. Reporters for the 3′ UTRs and for the whole inserted
cDNAs of FAM76A were repressed by miR-34a (Figs. 2F and 3 A
and B), and the repression of the reporter activity of the 3′ UTR
FAM76A reporter by miR-34a was reversed when its predicted
target sites were mutated (Fig. 3 A and B). These data indicate that
FAM76A was directly regulated by miR-34a via its 3′ UTR. In
contrast, the activity of the GFRA3 reporter including only the
coding region was repressed by miR-34a induction (Fig. 2F). To
test whether GFRA3 was directly regulated by miR-34a in its
coding region, target candidate sites of miR-34a in the GFRA3
coding region were searched. As a result, three sites that are per-
fectly consistent with the complementary seed sequence of miR-
34a were found in the GFRA3 coding region (Fig. 3C). Of note,
these sequences were present in each of the three GDNF (glial cell
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Fig. 3. FAM76A and GFRA3 are directly regulated
by miR-34a. (A) The five FAM76A reporters tested in
the luciferase assay. 3U, 3′ UTR; mut, sequences with
a point mutation; WT, wild-type sequences. (B) Lu-
ciferase assays of various FAM76A reporters in
293FT cells transfected with pcDNA-miR-34a or the
empty vector. (C) Sequences of the three candidate
sites (sites 1–3) for miR-34a targets in the GFRA3
coding region. Sequences with a point mutation in
the target candidate sites are shown below. (D) Lu-
ciferase assays of various GFRA3-CDS reporters in
293FT cells transfected with pcDNA-miR-34a or the
empty vector. ns, not significant. (E) Western blot
analysis of wild-type FLAG-GFRA3 [F-GFRA3 (Wt)] or
FLAG-GFRA3-mut [F-GFRA3 (Mut1/2/3)] in 293FT cells
cotransfection with pcDNA-miR-34a (miR34a) or the
empty vector. ***P < 0.001.
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line-derived neurotrophic factor) domains and located near this
domain (between α-helix 2 and α-helix 3) (Fig. S9). Reporter assays
using a GFRA3 coding-region reporter with point mutations with-
out amino acid sequence changes in the miR-34a target candidate
sites revealed that these three sites were direct target sequences of
miR-34a (Fig. 3D). In addition, Western blot analysis using ex-
pression vectors of FLAG-tagged GFRA3 with or without point
mutations in target sequences showed that FLAG-GFRA3 was
repressed by miR-34a, but the repression by miR-34a was reversed
in mutated FLAG-GFRA3 (Fig. 3E). Furthermore, we performed
AGO2-CLIP analysis in miR-34a mimic-overexpressing or negative
control miRNA mimic-overexpressing MDA-MB-231 cells. Target
mRNA sequences of FAM76A and GFRA3 were more concen-
trated in AGO2-binding mRNAs when miR-34a was overexpressed
(Fig. S10), indicating that miR-34a directly binds FAM76A and
GFRA3 mRNAs. These data indicate that miR-34a directly regu-
lates GFRA3 expression via these three target sequences in its
coding region.
GFRA3 Regulates the Growth of MDA-MB-231 Breast Cancer Cells.
miR-34a, which is a known tumor suppressor, represses the
growth of tumor cells, including breast cancer cells. To test whether
these newly identified targets are important for the function of
miR-34a, we analyzed the impact of the knockdown of target genes
on the growth of MDA-MB-231 breast cancer cells. The knock-
down of FAM76A and GFRA3 was successfully implemented using
two independent siRNAs of each gene (Fig. S11). A cell-viability
assay using the RealTime-Glo MT Cell Viability Assay (Promega)
in MDA-MB-231 cells transfected with the miR-34a mimic in-
dicated that cell viability was reduced by overexpression of the
miR-34a mimic, as previously reported (Fig. 4A) (19). Cell viability
was reduced in MDA-MB-231 cells in which the activity ofGFRA3
was reduced by two siRNAs (Fig. 4A). In addition, the knockdown
of GFRA3, but not FAM76A, led to a significant decrease in the
ability of MDA-MB-231 cells to form colonies (Fig. 4 B and C).
These data show that although FAM76A is not necessary for the
growth of MDA-MB-231 breast cancer cells, GFRA3 is an im-
portant target of miR-34a function in tumor growth suppression.
Expression Analysis of GFRA3 and miR-34a in Breast Cancer. We
found that GFRA3, a direct target of miR-34a, regulates the
growth of breast cancer cells. A recent study showed that
GFRA3 expression is significantly associated with survival in
patients with breast cancer (49). In addition, miR-34a expression
negatively correlates with tumor grades and stages (19). These
results suggest that GFRA3 expression negatively correlates with
miR-34a expression in breast cancer. Initially, we analyzed the
expression of GFRA3 in breast cancer tissues and found that
GFRA3 expression correlated with the overall survival (OS) of
breast cancer patients (Fig. 5A). Next, we analyzed the relation
between miR-34a and GFRA3 expression. The expression of
GFRA3 tended to be higher in breast cancer tissues with weaker
miR-34a expression than in tissues with stronger miR-34a ex-
pression (Fig. 5B). In addition, we analyzed the relation between
expression levels of miR-34a and GFRA3mRNA only inGFRA3+
breast cancer tissues. The GFRA3 expression levels were found
to have a significant negative correlation with miR-34a expression
according to Spearman’s rank correlation test (Spearman’s
ρ −0.2242, P = 0.0273), although overall samples did not cor-
relate (Spearman’s ρ −0.1024, P = 0.1667) (Fig. S12). These
data suggest that the targeting of GFRA3 by miR-34a is an
important component of its tumor-suppressor function.
Discussion
We constructed a reporter plasmid library that includes 4,891
cDNAs in the 3′-UTR region of a luciferase gene and used this
library to screen for targets of a miRNA. By means of this
system, we identified three previously unidentified target genes
of miR-34a.
Generally, two major miRNA-dependent regulatory mecha-
nisms repress target mRNA expression: induction of mRNA
instability or inhibition of the translation of protein from
mRNA. To identify miRNA target mRNAs that are regulated
by mRNA instability, transcriptome analysis in loss- or gain-of-
function experiments combined with other approaches such as
in silico prediction tools or genome-wide direct interaction anal-
ysis by pull-down methods are useful; however, the targets of
miRNA that are regulated at the translational level are difficult to
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Fig. 4. GFRA3 regulates the growth of MDA-MB-
231 cells. (A) A cell-viability assay of MDA-MB-231 cells
transfected with miRNA mimics or siRNAs using the
MT Cell Viability assay. (B) MDA-MB-231 cells
were transfected with miRNA mimics or siRNAs,
cultured for 2 wk, and then stained with crystal
violet. (C ) Colony numbers were determined by
counting the crystal violet-stained cells. **P <
0.01, ***P < 0.001.
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survey. Our data indicate that CARKL and REM2 expression
levels were decreased at the protein level by induction of a miR-
34a mimic in MDA-MB-231 cells but were not reduced at the
mRNA level (Fig. 2 C–E). In addition, miR-146a, which is induced
by NFκB and acts as a negative feedback regulator of the innate
immune response by targeting two adapter proteins, TRAF6
(TNF receptor-associated factor 6) and IRAK1 (IL-1 receptor-
associated kinase 1) (50), regulates its targets mainly at the level
of translation. The protein levels of TRAF6 and IRAK1 are
markedly increased in miR-146a–knockout macrophages com-
pared with wild-type macrophages, but the expression of TRAF6
and IRAK1 genes is not affected at the mRNA level (51). These
data indicate that our system is useful for the identification of
miRNA targets not only at the mRNA stability level but also at the
translation level.
We established thatGFRA3 is directly regulated by miR-34a via
binding in its coding region. miRNA target-prediction tools such
as TargetScan search for sequence matches between miRNA seed
sequences and 3′-UTR sequences. Here, we identified a target
that did not match any target prediction algorithms.
Although it is believed that miRNAs mostly recognize the 3′
UTR of targeted mRNAs, a recent unbiased study on the identi-
fication of target regions of mRNAs at the transcriptome level (by
CLIP analysis) revealed that the coding region of mRNA could be
targeted physically by a miRNA-containing RISC complex (7–9,
52). In this regard, several miRNAs have been shown to regulate
target mRNAs via their coding regions (53–56). In these reports,
miRNA-dependent regulation via a coding region has been proved
by endogenous expression changes caused by miRNA and a
reporter assay using a reporter with a point mutation. We also tested
to confirm the regulation ofGFRA3 by miR-34a via its coding region
by endogenous expression changes caused by miR-34a over-
expression and luciferase assays using GFRA3-CDS reporters with
point mutations for miR-34a targeting sites in this study. In addition,
we found that target mRNA sequences of GFRA3 were more con-
centrated in AGO2-binding mRNAs when miR-34a was overex-
pressed, indicating that miR-34a directly bindsGFRA3mRNAs (Fig.
S10). These data strongly indicate the coding region-mediated direct
regulation of GFRA3 by miR-34a. In addition, transcriptome-wide
mRNA–miRNA mapping analyses, such as AGO-CLIP, revealed
that the largest proportion (20–50%) of clusters is present in both 3′
UTRs and coding regions (7–9, 52), suggesting that miRNA targets
that are regulated via their coding sequence (CDS) may abound.
GFRA3 is an artemin receptor, which is a growth factor be-
longing to the GDNF family (57). The artemin–GFRA3 axis is
important for a diverse range of physiological functions including
the development and maintenance of various neuronal populations
(58), neurite outgrowth (59), and nerve regeneration (60, 61). The
artemin–GFRA3 axis is also important for tumor development.
GFRA3 expression is significantly associated with the survival
outcomes of patients with breast cancer, and coexpression of artemin
with GFRA3 produces a synergistic increase in the odds ratio for both
relapse-free andOS (49).We showed a significant association between
GFRA3 expression and OS in patients with breast cancer (Fig. 5A). In
addition, a knockdown of GFRA3 in MDA-MB-231 breast cancer
cells inhibited the growth of the cells; similarly, overexpression of
miR-34a reduced cell growth (Fig. 4 A–C). These data suggest
that the inhibition of breast cancer growth by miR-34a was caused,
at least in part, by the down-regulation of GFRA3.
Thus, our screening for the targets of miR-34a using a newly
prepared reporter library system revealed functional and systematic
direct targets of miR-34a, including GFRA3, whose target region is
located in its CDS. We also showed that the newly identified
p53→miR-34a→GFRA3 molecular axis has tumor-suppressive
functions in breast cancer. These data indicate that the reporter
library system is useful for identifying functional targets of miRNAs
in various regions in the targets and at various posttranscriptional
stages. This method also should be applicable to the search for
functional targets of specific RNA-binding proteins. Application of
this strategy should accelerate the research into miRNA-
dependent biology and pathologies and may uncover new rules
of gene-expression regulation at posttranscriptional levels.
Methods
Two hundred samples of breast carcinomas from 2003–2008 for the mRNA
assay came from the archive of the Department of Breast and Endocrine
Surgery, Nagoya City University Hospital, Nagoya, Japan. Informed consent for
the use of these samples had been obtained at the time of the surgical pro-
cedure. This protocol was approved by the Institutional Review Board of
Nagoya City University Graduate School of Medical Sciences and conformed to
the guidelines of the Declaration of Helsinki.
Cell-based screening for the targets of miRNAs using a reporter library was
performed by modifying a previously described method (62). Five microliters
of OPTI-MEM containing 0.15 μL of FuGENE HD (Promega), 20 ng of pcDNA-
miR-34a, pcDNA-miR-146a, or pcDNA3.1(+), and 5 ng of pRL-SV40 (Promega)
Renilla luciferase construct was added to the 384-well reporter library plates
and incubated for 20 min. Then 293FT cells (Invitrogen) in 40 μL of DMEM
containing 10% of FBS were added into each well using an automated mul-
tidispenser ECO DROPPER III (AS ONE). The cells were cultured in a 5% CO2
incubator at 37 °C for 24 h. Then 5 μL of the culture medium with or without
0.5 nL of 1 mM wortmannin (Sigma) stock solution, which was diluted in DMSO,
was added into each well (final concentration 100 nM). The cells were cultured in
a 5%CO2 incubator at 37 °C for 5 h. Luciferase activity wasmeasured bymeans of
an ARVO X3 (PerkinElmer) and the Dual-Glo Luciferase Assay System (Promega).
Overviews of the system and procedure are shown in Fig. 1A and Fig. S13.
For additional information on methods, see SI Materials and Methods.
ACKNOWLEDGMENTS. We thank Drs. Akio Yamashita, Masato Yano,
Tomoaki Tanaka, and Kazuhiko Kuwahara for helpful discussions and Mayuko
A
B
Fig. 5. Expression of GFRA3 in breast cancer. (A) Kaplan–Meier analysis of
the effect of GFRA3 expression on OS among breast cancer patients. (B) The
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miR-34a expression level.
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